Everyone Is Wearing a Glucose Monitor Now. Most of Them Do Not Have Diabetes.
Dr. Dereck Mush, MD, MBA
What they do
Glooko offers a digital health platform that aggregates clinical data from over 190 different diabetes and metabolic tracking devices. The software enables healthcare providers to remotely monitor patient progress and make data-driven clinical decisions to improve disease management.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Diabetes data platform
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- Palo Alto, USA
- Region
- North America
- Founded
- 2010
- Total funding
- $151M raised
Notable investors: Georgian, HealthPlayground, Insulet Corporation, Mayo Clinic.
Also in Metabolic Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
Continuous glucose monitors are now a mainstream wellness product. The evidence base has not fully kept pace
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
Automated Insulin Delivery Just Got FDA Clearance for Type 2 Diabetes. What Changes for the Pump Market
Dr. Dereck Mush, MD, MBA